ETV6 and nasopharyngeal carcinoma: Treatment with the BRD4 inhibitor JQ1 significantly suppresses super-enhancer-associated ETV6 gene expression and induces nasopharyngeal carcinoma cell growth inhibition [37] (Table 1).